Steven D. Schwartz, MD

Vitreoretinal Surgeon
Portrait of Dr. Steven D. Schwartz, MD, Vitreoretinal Surgeon at Retina Vision Consultants

Dr. Steven Schwartz is an internationally renowned vitreoretinal surgeon and translational scientist who helped pioneer anti-VEGF therapy—the injections now used worldwide to treat macular degeneration. Perhaps best known for advancing gene and stem cell treatments for macular diseases, his innovations in diagnostic imaging, surgical instrumentation, and drug delivery have become standard care in retina centers across the globe.

As former Ahmanson Chair, Professor of Ophthalmology, and Retina Division Chief at UCLA’s Jules Stein Eye Institute, Dr. Schwartz has published over 250 peer-reviewed papers, trained more than 60 vitreoretinal fellows, and delivered prestigious international lectures including the Royal Society of Medicine and The Emperor’s Lecture in Tokyo.

Languages: 

English, Spanish

"My passion is preventing preventable vision loss. So much blindness is preventable—just with access, early diagnosis, and proper treatment."

— Dr. Steven D. Schwartz

Meet Dr. Prasad

Professional Background

Education & Training

Vitreoretinal Surgery Fellowship
Jules Stein Eye Institute, UCLA | 2009–2011

Ophthalmology Residency
Jules Stein Eye Institute, UCLA | 2006–2009

Medical Internship
West Los Angeles Veterans Administration | 2005–2006

Doctor of Medicine (MD)
David Geffen School of Medicine at UCLA | 2005

Master of Business Administration (MBA)
UCLA Anderson School of Management | [Year]
Alpha Omega Alpha Medical Honor Society

Current Hospital Affiliations:

  • Harbor-UCLA Medical Center
  • Olive View-UCLA Medical Center
  • Specialty Surgical Center of Beverly Hills
  • Providence Saint John’s Health Center


Professional Memberships:

  • American Academy of Ophthalmology
  • American Society of Retina Specialists
  • The Retina Society
  • Association for Research in Vision and Ophthalmology (ARVO)
  • Castle Connolly Top Doctor — Since 2023
  • Super Doctors® Southern California — 2026
  • UCLA Department of Ophthalmology Fellow Teaching Award
  • UCLA Department of Ophthalmology Faculty Teaching Award

Dr. Prasad has authored numerous peer-reviewed scientific papers and book chapters on vitreoretinal disease and surgical outcomes. He serves as a reviewer for multiple medical journals and has been an invited lecturer at national and international ophthalmology conferences.

Current Research Interests:

  • Stem cell therapies for age-related macular degeneration
  • Novel approaches to diabetic retinopathy management
  • Clinical outcomes in vitreoretinal surgery
  • Providence Saint John’s Health Center

What Patients Are Saying

Visit Us

360 N. Bedford Drive, Floor 3 Beverly Hills, CA 90210

Request an Appointment

Fill out the form below and our team will be in touch.

Treatment Options at RVC

Intravitreal Injections (Anti-VEGF Therapy)

The most common treatment for wet AMD, diabetic eye disease, and retinal vein occlusion. A brief, in-office injection delivers medication directly to your retina to stop vision loss and, in many cases, improve vision.

Photobiomodulation

A painless, non-invasive light therapy for intermediate dry AMD — the first FDA-authorized treatment to improve vision in dry macular degeneration. No injections, no surgery, and sessions take just minutes.

Pneumatic Retinopexy

An in-office procedure to repair select retinal detachments without an operating room. A gas bubble is injected to press the retina back into place — the least invasive detachment repair with the best visual outcomes for appropriate cases.

Retinal Laser Therapy

An in-office procedure that uses focused light to seal retinal tears, treat diabetic eye disease, and prevent further vision loss. Several laser types are available depending on your condition.

Treatment Options at RVC